Clinical Trial Update: Tislelizumab in People With Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating tislelizumab for colorectal cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Tislelizumab (tislelizumab)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Colorectal Cancer | Phase 2 | Status: RECRUITING